The FDA has approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection. Siliq...
Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. announced results from the pivotal Phase III long-term extension study (AMAGINE-2),...
Ortho Dermatologics announced results from an analysis of the Phase III clinical trial AMAGINE-1, which evaluated mental health comorbidities associated...
Valeant Pharmaceuticals International, Inc. announced that following the evaluation and approval of its Patient Access and Pricing Committee (PAPC), the...
LEO Pharma has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European...
The UK NICE has recommended the use of Tremfya (guselkumab), from Janssen, as a cost-effective treatment for plaque psoriasis for...
AstraZeneca and MedImmune, announced that its partner Leo Pharma has been granted full marketing authorisation in all 28 EU member...
Janssen Biotech, Inc. announced that the FDA has approved Tremfya (guselkumab) for the treatment of adults living with moderate to...